Innovate a high-performance network.
Shortages of specialists mean long wait times and a lack of follow-up in today's GI care. In turn, this drives unnecessary emergency room and urgent care visits for patients bouncing around a system and receiving duplicate appointments and tests. For most, when they finally receive care, it's in the form of expensive procedures with limited follow-up or resources to address symptom management, mitigate flare-ups, and promote relief.
This lack of supportive follow-on GI care leaves chronic sufferers feeling anxious and underserved. Yet Salvo Health has shown that evidence-based, comprehensive protocols can not only bring patients quick relief but relief that lasts.
Through value-based care bundles with risk components, Salvo Health can help payers expand access and improve clinical outcomes while reducing costs.
Our tech-enabled, virtual-first model allows referred patients to be seen within 48 hours via video visit by a Salvo Health board-certified physician or nurse practitioner. After an initial visit and intake, patients appropriate for Salvo Health's program can begin their personalized care plan.
Comprehensive Care Management
Our bundled program is team-based, with a care plan overseen by a board-certified physician, an allied team of nurses, licensed social workers, a registered dietician, and digital programs in gut-directed nutrition, psychotherapy, and cognitive behavior therapy.
Keep Patients Happy & On Track
On average, Salvo Health members communicate with their Care Teams daily, self-report clinical symptoms twice a week, and 97% of those with severe symptoms at intake report feeling better within 4+ weeks.
Increase Cost Savings
Our virtual platform expands access, meeting your members where they are on their gut health journey. We provide members with the tools and daily support for long-term relief while decreasing the use of unnecessary procedures and costly emergency and urgent care visits.
On average, Salvo Health members communicate with their Care Teams daily, self-report clinical symptoms twice a week, and 97% of those with severe symptoms at intake report feeling better within 4 weeks.